MedStar Authors catalog › Details for: TCT-421 In Vivo Serial Assessment of Coronary Vessel Geometry Restoration and Resorption Process Following the Implantation of Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial.
Normal view MARC view ISBD view

TCT-421 In Vivo Serial Assessment of Coronary Vessel Geometry Restoration and Resorption Process Following the Implantation of Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial.

by Garcia-Garcia, Hector M; Waksman, Ron.
Citation: Journal of the American College of Cardiology. 68(18S):B170, 2016 Nov 01.Journal: Journal of the American College of Cardiology.Published: 2016ISSN: 0735-1097.Full author list: Garcia-Garcia HM; Haude M; Ince H; Abizaid A; Toelg R; Lemos P; von Birgelen C; Christiansen E; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Lim ST; Escaned J; Waksman R.UI/PMID: 27969774.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.jacc.2016.09.556 (Click here) Abbreviated citation: J Am Coll Cardiol. 68(18S):B170, 2016 Nov 01.Local Holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007.

Powered by Koha